Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

52:41
 
Share
 

Manage episode 495124768 series 3381584
Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Uncover the forces driving change in global pricing and access
In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).
At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.
Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.
This episode was first broadcast as a live webinar. Learn more at: https://petauri.com/insights/webinar-global-pricing-market-access-strategies/
Discover our global pricing and market access services at: https://petauri.com/gpma/
To explore your pricing and market access strategy with our experts or to put your question to the panel, email [email protected]
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  continue reading

Chapters

1. Welcome and introductions (00:00:00)

2. Global trends in pharmaceutical pricing and market access strategies (00:04:55)

3. Global impact of US Most Favored Nation (MFN) pricing reforms (00:09:30)

4. Impact of HTA collaborations: JCA and Commonwealth (00:13:59)

5. Defining a global pricing strategy (00:18:11)

6. Role of early payer engagement in launch success (00:25:34)

7. Market access for rare disease and innovative therapies (00:31:50)

8. Innovative pricing agreements (00:37:58)

9. Preparing for competitors in the market (00:43:20)

10. Final nuggets of advice from our experts (00:47:15)

69 episodes

Artwork
iconShare
 
Manage episode 495124768 series 3381584
Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Uncover the forces driving change in global pricing and access
In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).
At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.
Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.
This episode was first broadcast as a live webinar. Learn more at: https://petauri.com/insights/webinar-global-pricing-market-access-strategies/
Discover our global pricing and market access services at: https://petauri.com/gpma/
To explore your pricing and market access strategy with our experts or to put your question to the panel, email [email protected]
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  continue reading

Chapters

1. Welcome and introductions (00:00:00)

2. Global trends in pharmaceutical pricing and market access strategies (00:04:55)

3. Global impact of US Most Favored Nation (MFN) pricing reforms (00:09:30)

4. Impact of HTA collaborations: JCA and Commonwealth (00:13:59)

5. Defining a global pricing strategy (00:18:11)

6. Role of early payer engagement in launch success (00:25:34)

7. Market access for rare disease and innovative therapies (00:31:50)

8. Innovative pricing agreements (00:37:58)

9. Preparing for competitors in the market (00:43:20)

10. Final nuggets of advice from our experts (00:47:15)

69 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play